Company intelligence / Profile preview

DRS Industries

Ownership: Private
Development stage: Other

Overview

DRS Biopharma is a pharmaceutical company established in 2023, specializing in innovative drug delivery systems—particularly orally disintegrating films. The company emphasizes quality, regulatory compliance, and affordability. It has a strong presence across Southeast Asia and focuses on enhancing patient compliance with novel formulations. No clinical trial data or results are disclosed; the business appears to be commercial-stage with an emphasis on manufacturing and export rather than new drug development or clinical research.

Therapeutic areas: Other
Modalities: Orally disintegrating film medicinesSpecialized pharmaceutical formulations
Industry: Biotech

Beyond the preview

Go deeper on DRS Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DRS Industries.

Explore the full profile